|
Match
|
Document |
Document Title |
|
|
5990160 |
Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
The present invention concerns the use of puberulic or puberulonic acid as inhibitors of the enzyme iositol monophosphatase (EC 3.1.3.25) and thus useful in the treatment of manic or depressive...
|
|
|
5985310 |
Preservative systems for pharmaceutical compositions containing cyclodextrins
Disclosed are preservative systems useful in aqueous pharmaceutical compositions containing an active agent and a cyclodextrin. The preservative systems comprise boric acid and one or more...
|
|
|
5973010 |
Composition for healing skin wounds
A composition and method for treating epidermal wounds utilizes an aqueous solution of sodium sulphate, sodium carbonate, sodium bicarbonate, sodium chloride and ichthammol.
|
|
|
5972993 |
Composition and method for treating rosacea and sensitive skin with free radical scavengers
A method for treating skin conditions, such as rosacea and sensitive skin, that manifest as a tendency towards flushing and blushing is provided. Also provided herein, are compositions for the...
|
|
|
5965619 |
Method for treating patients having precancerous lesions with substituted indene derivatives
Substituted indene derivatives are useful for treating patients having precancerous lesions and for inhibiting the growth of neoplastic cells.
|
|
|
5958975 |
Antiodor, antimicrobial and preservative compositions and methods of using same
Therapeutic treatment as well as prophylactic measures are provided by topical application of compositions containing an aryl 2-acetoxyethanoic acid to eradicate or prevent the development of...
|
|
|
5922335 |
Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
Novel uses of 3'-(L-ascorbyl-2-o-phosphoryl)-cholesterol, 3'-(L-ascorbyl-3-o-phosphoryl)-cholesterol, structural or functional isomers thereof and salts thereof (referred to collectively as "APC...
|
|
|
5906985 |
Pharmaceutical compounds
Pharmaceutical compounds of the formula ##STR1## in which n is 0, 1 or 2 and m is 1 or 2, R 1 is hydrogen, C 1 -10 alkyl, C 2 -10 alkenyl, C 2 -10 alkynyl, phenyl, naphthyl, C 1 -10 alkyl-phenyl,...
|
|
|
5902590 |
Cosmetic and/or pharmaceutical formulations
A cosmetic or pharmaceutical composition containing an emulsifier comprising an ester of palmitic acid and technical grade triglycerol with the proviso that the monoester content of the ester is...
|
|
|
5902827 |
Method for treating patients with psoriasis by administering substituted sulfonyl indenyl acetic acids, esters and alcohols
Substituted indenyl sulfonyl acetic acids, esters and alcohols are useful in the treatment of psoriasis.
|
|
|
5883083 |
Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
A dietary supplement for canines and felines includes taurine in a liquid lecithin base. The dietary supplement has proven effective in reducing epileptic seizures in canines and in reducing...
|
|
|
5863563 |
Treatment of pulmonary conditions associated with insufficient secretion of surfactant
Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described....
|
|
|
5851537 |
Topical application of α-DFMO for preventing skin cancer
A salve includes a water-miscible, hydrophilic cream vehicle, 1-22% by weight a-DFMO, and no absorption enhancer. The salve is preferably contained in an ointment tube permanently sealed at one end...
|
|
|
5807600 |
Reduction of cutaneous atrophy
The cutaneous atrophy associated with the use of steroids topically can be ameliorated using salts of certain α-hydroxyacids.
|
|
|
5786381 |
Cosmetic composition
A cosmetic composition comprising a hydroxy material selected from a layered double hydroxides and hydroxy salts which is suitable for treating the skin and delivering thereto the benefit agents.
|
|
|
5767110 |
Combination chemotherapy
Suramin in combination with a vinca alkaloid or estramustine is synergistic for treating cancer.
|
|
|
5753611 |
Pharmaceutical composition having site-specific delivery
Use of α-hydroxy acids and poly-α-hydroxy acids as spacer between a therapeutically and/or diagnostically active compound and a soluble macromolecular carrier in pharmaceutical compositions...
|
|
|
5750093 |
33 Lipomelanin sunscreen composition
A novel lipomelanin sunscreen complex includes melanin linked to a lipid to form a lipomelanin. One or more ultra-violet-light absorbing compounds can be added to form a lipomelanin sunscreen...
|
|
|
5733539 |
Bait for fishes and shellfishes
The invention discloses a bait for fishes and shellfishes characterized in that the bait comprises a matrix material containing a microorganically fermented product of a plant residue obtained by...
|
|
|
5718888 |
Deodorant active-substance combinations made from wool-grease acids and partial glycerides
Cosmetic deodorants containing mixtures of I) wool wax acids or wool wax acid components, and II) fatty acid partial glycerides of unbranched fatty acids.
|
|
|
5718887 |
Deodorizing active compound combinations based on α,Ω-alkanedicarboxylic acids and monocarboxylic acid esters of oligoglycerols
Cosmetic deodorants comprising mixtures of I) one or more α,Ω-alkanedicarboxylic acids and II) one or more monocarboxylic acid esters of di- and/or triglycerol.
|
|
|
5714509 |
Inhibitors of bacterial sialidase and methods of making and using the same
A sialidase inhibitor of the shown formula I: ##STR1## where dashed lines d 1 and d 2 , X 1 , R 1 , R 2 , R 6 , R 3 , R 4 and R 5 are as described in the specification; or an analog,...
|
|
|
5705199 |
Animal control substance and method of use
A substance produced from a combination of acid based ingredients and a mole attracting herb. Placement of the substance into a mole tunnel attracts the mole and upon contact with the substance...
|
|
|
5690919 |
Deodorizing cosmetic compositions
Use of a mixture of (a) dodecanoic acid (lauric acid) (b) at least one other fatty acid, selected from the group of unbranched saturated fatty acids having a chain length of C 6 -20, at least...
|
|
|
5665371 |
Medicines which contain derivatives of proline or hydroxyproline
Pharmaceutical compositions which comprise, as an active substance, (N-alkyl) derivatives of proline or hydroxyproline. Such compositions are useful in the treatment of cancer.
|
|
|
5658595 |
Method, composition and device for the treatment of raw materials, products and production means, in particular in the foodstuffs industry
A mixture of hydrogen peroxide and glycerol has been found to be a particularly effective composition as a preserving additive for raw materials, in particular foodstuffs. An organic acid, such as...
|
|
|
5656277 |
Nor- and homo- bile acids derivatives as absorption enhancers for medicaments
The use of nor- and homo-bile acids derivatives as absorption enhancers for medicaments is described. Said derivatives show the advantage of improving the absorption of medicaments through mucosae...
|
|
|
5643554 |
Lipomelanim composition
A novel lipomelanin sunscreen complex includes melanin linked to a lipid to form a lipomelanin. One or more ultra-violet-light absorbing compounds can be added to form a lipomelanin sunscreen...
|
|
|
5643949 |
Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use
Therapeutic as well as preventative measures to improve the cosmetic conditions or to alleviate the symptoms of dermatologic disorders with phenyl alpha acyloxyalkanoic acids and derivatives is...
|
|
|
5643945 |
Eatable taste modifiers
Ingestible compounds which are substantially tasteless and which have been found to be effective reducers or eliminators of undesirable tastes for eatables.
|
|
|
5607691 |
Compositions and methods for enhanced drug delivery
The present invention relates to methods of delivering pharmaceutical agents across membranes, including the skin layer or mucosal membranes of a patient. A pharmaceutical agent is covalently...
|
|
|
5605932 |
Opiate receptor ligands
Compounds of Formula 1 bind opioid receptors: which binds to the opioid receptor: ##STR1##
|
|
|
5594031 |
Methods and compositions for the treatment of the skin
The invention relates to a method of skin treatment comprising the step of topically applying to skin affected by seborrheic dermatitis an amount of a composition comprising an excipient and from...
|
|
|
5594030 |
Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid
Controlled release pharmaceutical compositions administrable by oral route, containing as the active principle at least one salt of the gamma hydroxy butyric acid with a pharmaceutically acceptable...
|
|
|
5583089 |
Bicarbonate salt pesticide composition containing a clathrate spreader-sticker ingredient
This invention provides a dry blend pesticide composition which contains a fungicidal bicarbonate salt ingredient, and a spreader-sticker ingredient which is a crystalline clathrate complex of a...
|
|
|
5576316 |
Method for inhibiting tumor growth rate using creatine or creatine analogs
A method for inhibiting tumor growth rate using creatine or creatine analogs is described. The creatine or creatine analogs are administered to subjects such that tumor growth rate is inhibited....
|
|
|
5574089 |
Water-based latex compositions containing boric acid
Improved water-based latex compositions are provided comprising a water-based latex emulsion and boric acid. It has been surprisingly found that by adding boric acid to water-based latex emulsions...
|
|
|
5552440 |
Use of L-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer
A pharmaceutical composition of canavanine, and a method treatment of cancer, particularly pancreatic cancer with L-canavanine is disclosed.
|
|
|
5547946 |
Topical pharmaceutical compositions for respiratory allergies
A method and topical pharmaceutical composition for treating respiratory allergies, allergic rhinitis, allergic conjunctivitis, allergic asthma, and allergy to fur and dust, in which free ion...
|
|
|
5538957 |
Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds
Compounds of the formula (I) in which: R is a possibly substituted amino group of the general form --NR 1 R 2 , in which R 1 and R 2 are independently hydrogen, lower alkyl, lower alkenyl or...
|
|
|
5536646 |
Simplified extraction method for bacterial antigens using dried reagents
Polysaccharide antigens characteristic of Group A or B Streptococci are extracted for use in immunodiagnostic assays by a simplified method. The method involves the use of two dried reagents,...
|
|
|
5525347 |
Composition and methods for treating performance anxiety
The invention provides a pharmaceutical composition for treating performance anxiety and social phobia comprising a therapeutic amount for the treatment of a patient of a β-adrenergic receptor...
|
|
|
5525354 |
Pharmaceutical preparation and process for its manufacture
In a pharmaceutical preparation for oral use containing a pharmacologically acceptable salt of a bisphosphonic acid, the improvement comprising: a drug delivery form of the preparation which is...
|
|
|
5523078 |
Method of preparing and composition for treatment of hair and scalp
An aqueous composition for the treatment of hair and scalp which includes a chelating agent, gellan gum, a vitamin precursor, a preservative, biotin, a vitamin derivative, γ-linolenic acid,...
|
|
|
5500418 |
Aminoalkanephosphinic acids and salts thereof
Compounds of formula I ##STR1## wherein R is diethoxymethyl, R 1 is hydrogen, R 2 is pyrid-3-ylmethyl and R 3 is hydrogen, or R is cyclohexylmethyl, R 1 is hydrogen and R 2 is...
|
|
|
5494922 |
Allophanic acid derivatives
The invention concerns allophanic acid derivatives of formula I R 1 --N(R 2 )CO--N(R 3 )CO--X 1 --Q--X 2 --GI and pharmaceutically acceptable metabolically labile esters or amides thereof, and...
|
|
|
5475030 |
Complexes of tellurium and selenium derivatives
A novel complex of a class of tellurium and selenium compounds is disclosed, which is based on a complexing agent and the particular compound to be complexed.
|
|
|
5472698 |
Composition for enhancing lipid production in skin
Skin treatment compositions for the enhancement of lipid production in the skin. Compositions contain a thiol, or an S-ester, in combination with L-serine or N-acetyl-L-serine.
|
|
|
5463011 |
Acid derivatives
The invention concerns allophanic acid derivatives of formula I R 1 --N(R 2 )CO--N(R 3 )CO--X 1 --Q--X 2 --GI and pharmaceutically acceptable metabolically labile esters or amides thereof, and...
|
|
|
5451405 |
Skin treatment composition
It should be understood that the specific forms of the invention herein illustrated and described are intended to be representative only. Changes, including but not limited to those suggested in...
|